Regional Analysis
Global Plasma Expander Market Regional Insights
- North America is the largest market for plasma expanders, which accounted for 35.1% of the global market share in 2022. This is due to the constantly increasing inorganic growth strategies such as acquisition in the region, as well as the presence of a large number of key market players. For instance, Grifols a pharmaceutical company acquired seven U.S. plasma donation centers from Kedrion. U.K for US$ 55.2 Mn . This seven donation centers are authorized by the U.S. Food and Drug Administration (FDA) and European healthcare authorities. Through this center, Grifols gain immediate access to the plasma obtained in these centers, which is approximately 240,000 liters per year.
- Europe is the second-largest market for plasma expanders, which accounted for 25.4% of the global market share in 2022. The market growth is driven by the increasing demand for plasma expanders in the critical care setting, as well as the rising prevalence of cardiovascular diseases in the region.
- Asia Pacific is the third-largest market for plasma expanders, which accounted for 22.5% of the global market share in 2022. The market growth is driven by the rising prevalence of chronic diseases and trauma in the region, as well as the increasing investment in healthcare infrastructure.
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
|
U.S.: 
U.K. : 
India : 
